Introduction: Diabetic nephropathy (DN) is a progressive renal disease characterized by persistent albuminuria that leads to end-stage renal disease in both type 1 diabetes (T1DM) and type 2 diabetes (T2DM) patients. The renin-angiotensin-aldosterone system (RAAS) plays a major role in the onset and progression of DN. Objectives: The present meta-analysis is intended to synthesize evidence on the association between ACE gene insertion and deletion (ACE I/D) polymorphism and the risk of DN. Methods: PubMed, Scopus, Google Scholar and Embase were searched to retrieve relevant publications. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to evaluate the association between ACE I/D polymorphism and DN risk. The Cochrane Q test and I 2 statistic were used to detect heterogeneity. To assess between-study heterogeneity, subgroup analysis and sensitivity analysis were performed. Funnel plots and Egger's test were used to estimate publication bias. Results: Around 45 articles (47 studies) with 6124 patients of DN and 2492 T2DM patients (controls) were ultimately considered for meta-analysis. Overall, the ACE I/D polymorphism was associated with DN under three different genetic models (allelic model: OR = 1.34; 95% CI: 1.20-1.49; P < 0.001; dominant model: OR= 1.54; 95% CI: 1.31-1.81; P < 0.001; and recessive model: OR= 1.39; 95% CI: 1.19-1.63; P < 0.001). Significant heterogeneity (I 2 > 50%) was present in the analysis for all ethnic groups. Further, there is no evidence for publication bias in this meta-analysis. Conclusion: The current meta-analysis provided confirmation that the ACE I/D polymorphism is correlated with an increased risk of DN in patients with T2DM and the D allele of ACE I/D was a susceptible factor.
Introduction
Diabetic nephropathy (DN) is one of the causes of renal impairment in type 1 diabetic (T1DM) or type 2 diabetic (T2DM) patients that leads to dialysis or kidney transplantation (1) . About 40% of people with diabetes develop DN. DN is characterized by reduced glomerulus function, increased albumin excretion through urine and gradual loss of renal function (2) . Chronic hyperglycemia linked with variations in blood pressure (BP) may adversely affect renal function. Hence maintaining blood sugar and controlling BP may delay the progression of DN (3) . Clustering of DN in T2DM families indicates a strong genetic susceptibility for its development and progression (4) . Therefore several genetic factors have been studied to unveil the predisposition to the development of DN in T2DM patients. Due to technical advances in DNA sequencing methods, several candidate susceptibility genes of DN have so far been identified and studied extensively (5) .
Several lines of evidence indicated that the reninangiotensin-aldosterone system (RAAS) regulating body's blood pressure is an independent risk factor of chronic kidney disease (CKD) (6) . Further, the use of angiotensinconverting enzyme (ACE) inhibitors prevents progression to CKD (7) . Therefore the genes involved in this RAAS pathway were studied for their association with the development of DN. ACE transforms angiotensin I to angiotensin II and consequently regulates the activity of angiotensin (8) . The expression of ACE was found in proximal tubule brush borders and glomerular endothelial cells of the kidney (9) .
The gene coding for ACE is located at chromosome region 17q23.3. Intron 16 of ACE gene has an insertion (I allele) and deletion (D allele) (ACE I/D) functional polymorphism. The D allele has been shown to result in higher levels of circulating ACE (10) . In recent years, the relationship between ACE I/D polymorphism and DN has been reported in many studies (11) . However, the correlation between ACE I/D and DN remains controversial. In the present study, we performed a metaanalysis to investigate whether ACE I/D polymorphism is associated with DN risk or not.
Materials and Methods

Literature search and selection
To synthesize evidence on the association between ACE gene I/D polymorphism and the risk of DN, a metaanalysis was conducted. For this purpose, PubMed, Scopus, Embase and Google Scholar were searched, to retrieve association studies published as of August 20, 2019. The keywords used were "angiotensin converting enzyme", "ACE", "ACE I/D", "diabetic nephropathy", "T2DN", "diabetic kidney disease" and "insertiondeletion polymorphism". The search of articles is restricted to the English language. Inclusion criteria were as follows: (1) article should study the association between type 2 diabetic nephropathy (T2DN) and ACE I/D polymorphism; (2) ; the study should provide ACE genotype distribution; (3) case-control study design; and (4) a comparison between a T2DN group and a T2DM control group. Exclusion criteria were as follows: (1) the study did not meet the inclusion criteria; (2) studies with ACE I/D polymorphism and T1DM and (3) articles not written in English. From all eligible studies, lead author's name, publication year, country of origin, ethnicity, and genotypes from T2DN and T2DM groups were collected.
Statistical analysis
The association between ACE gene I/D polymorphism and DN in T2DM were estimated for each study and pooled odds ratios (ORs) with a 95% confidence interval (CI) were calculated in allelic, dominant and recessive genetic models. The presence of heterogeneity between studies was assessed with the Q test and I 2 statistics. Randomeffects model (REM) or fixed-effects model (FEM) was used based on the presence or absence of heterogeneity. To test for robustness of the meta-analysis, we conducted a sensitivity analysis by excluding one study each time and estimating the pooled OR for the rest of the studies. The publication bias for comparisons was assessed by funnel plot and Egger's test. An ethnicity-based subgroup analysis was performed to assess the geographic-specific effects on the meta-analysis. Data for the meta-analysis were analyzed using a web tool MetaGenyo (12) .
Results
Study characteristics
The search strategy adopted in the meta-analysis is depicted in Figure 1 . Our systematic search identified 45 papers (47 studies) that analyzing the association between ACE gene I/D polymorphism nephropathy in T2DM patients. The study by Jayapalan et al included Malaysian, Chinese and Indian patients and hence it was considered as three independent studies (13) . The basic characteristics of each study along with their genotype frequencies of ACE gene I/D polymorphism were documented in Table 1 . The years of publication spanned from 1994 and 2018. The ACE I/D polymorphism deviated from Hardy-Weinberg (56) equilibrium (HWE) in control group of 11 studies (Table  1) . As the comparison group (T2DM) is already having selection, deviation from HWE is not a serious concern in this meta-analysis.
Association of ACE gene I/D polymorphism with susceptibility to DN
The forest plot depicts the relationship of ACE I/D polymorphism with DN in independent studies, as well as an overall pooled estimate in dominant model ( Figure  2) . As there is a significant between-study heterogeneity, the REM was used to estimate OR. : 64%). On stratification, both Asian populations and Caucasian populations showed a significant association between ACE I/D polymorphism and DN risk under any genetic models tested ( Table 2) .
Sensitivity analysis and publication bias
In sensitivity analysis, pooled effect estimates by omitting one study each time were depicted in Figure 3 . In the present meta-analysis, there was no substantial deviation in the levels of significance and OR when we omitted one study at a time. There is no evidence of asymmetry in the shape of the funnel's plot (Figure 4) . Further, Egger's test ( Table 2 ) also revealed no publication bias (D versus I: Egger's test P = 0.764; DD+ID versus II: Egger's test P = 0.157; DD versus ID+II: Egger's test P = 0.594).
Discussion
Based on 47 independent case-control studies, including 6124 patients of DN and 2492 T2DM patients (controls), we investigated the association between the ACE I/D polymorphism and DN risk. An significant association between the ACE gene I/D variant and DN risk was found in all genetic models. Sub-group analysis in Asian and Caucasian ethnic backgrounds also revealed a significant association between ACE I/D polymorphism and DN. Meta-analysis of studies on ACE I/D reveals significant heterogeneity between studies. Further, there is no evidence for publication bias on association between ACE gene I/D polymorphism and DN.
DN is one of the most common complications of longstanding T1DM and T2DM. Diabetic kidney disease is Almost double the prevalence of hypertension was found in diabetes patients as compared to the general population (57) . Although hypertension co-occurs with microalbuminuria or overt nephropathy in T1DM patients, it can be seen prior to kidney disease in T2DM patients (58) . Some studies suggested that hypertension is already occurred in newly diagnosed T2DM (59) . The development of hypertension in diabetics can partly be explained by the presence of increased inflammation and vascular dysfunction associated with the imbalance between angiotensin II-angiotensin1-7 (60) . Hence hypertension is one of the extremely important factors that influence the onset of nephropathy in T1DM or T2DM patients. It is widely recognized that the ACE inhibitor therapy could able to reduce the advancement of DN in patients with T1DM and T2DM (61) . Hence ACE is suspected to play a key role as antiproteinuric or renal protective agent. Further, reduced expression of ACE in kidneys of diabetic rats and human diseases suggests its involvement in DN (62) .
Diabetes Control and Complications Trial (DCCT) and the Epidemiology of Diabetes Interventions and
Complications (EDIC) cohort study on T1DM patients suggested that the ACE II genotype conferred a lower risk for persistent microalbuminuria and severe nephropathy (63) . In contrast to this, carriers of ID or DD genotype showed lower incidence of end-stage renal failure in T2DM patients (64) . However, the correlation between ACE I/D and DN remains controversial. Our findings from the present meta-analysis are consistent with the findings of the previous meta-analyses, in which significant association between the ACE gene I/D and DN risk was inferred (65) (66) (67) . In support of this higher ACE activity level was documented in DD and ID+DD carriers (40) .
Some limitations should be taken into consideration while interpreting our results. Although there is no difference in the ACE I/D genotyping methodology, there were still other existing heterogeneities, such as the diagnostic criteria of DN, selection of controls and race. Further, it should be noted that no access to the diet of subjects (salt and fat consumption) might modulate the effects of ACE I/D polymorphism in DN.
Conclusion
In conclusion, this meta-analysis demonstrated that ACE gene I/D is a risk factor for DN. Further research should be performed to investigate the interactions between hypertension, diabetes duration, RAAS pathway polymorphisms and the risk of DN.
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